CCAP · Crescent Capital Bdc, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | - | - | - | - | - | - | - | - | - | - |
| Total Operating Expenses | $23.29M | - | $24.16M | $25.74M | $25.06M | - | $27.54M | $26.85M | $26.75M | - |
| D&A | - | - | - | - | - | - | - | - | - | - |
| Operating Income | ($21.87M) | - | ($24.14M) | ($25.70M) | ($25.01M) | - | ($27.44M) | ($26.82M) | ($26.68M) | - |
| Interest Expense | $13.74M | - | $13.88M | $15.15M | $14.64M | - | $16.10M | $15.93M | $15.60M | - |
| Income Tax | - | - | $0 | $0 | $6.0K | - | $155.0K | - | - | - |
| Net Income | ($15.51M) | - | $7.10M | $15.01M | $3.90M | - | $15.27M | $20.39M | $28.00M | - |
| EPS - Basic | $0.42 | - | $0.46 | $0.46 | $0.45 | - | $0.64 | $0.59 | $0.63 | - |
| EPS - Diluted | $0.42 | - | $0.46 | $0.46 | $0.45 | - | $0.64 | $0.59 | $0.63 | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $6.14M | $5.04M | $5.79M | $9.74M | $12.03M | $10.13M | $17.09M | $11.02M | $6.74M | $7.78M |
| Accounts Receivable | - | - | - | - | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - | - | - | - | - |
| Accounts Payable | - | - | - | - | - | - | - | - | - | - |
| Current Assets | - | - | - | - | - | - | - | - | - | - |
| Total Assets | $1.62B | $1.62B | $1.63B | $1.65B | $1.67B | $1.66B | $1.65B | $1.67B | $1.62B | $1.63B |
| Current Liabilities | - | - | - | - | - | - | - | - | - | - |
| Long-term Debt | $907.13M | $873.76M | $875.32M | $887.32M | $902.95M | $875.84M | $857.24M | $879.93M | $831.43M | $844.78M |
| Total Liabilities | $943.63M | $916.10M | $913.55M | $929.73M | $939.38M | $915.64M | $896.24M | $919.99M | $868.67M | $884.78M |
| Stockholders' Equity | $674.03M | $706.04M | $714.08M | $724.72M | $727.12M | $740.64M | $748.81M | $752.44M | $751.70M | $742.59M |
| Retained Earnings | ($282.04M) | ($251.03M) | ($244.73M) | ($234.42M) | ($232.01M) | ($218.50M) | ($217.13M) | ($213.49M) | ($214.23M) | ($223.34M) |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ($23.80M) | - | - | - | ($15.13M) | - | - | - | $39.50M | - |
| Investing Cash Flow | - | - | - | - | - | - | - | - | - | - |
| Financing Cash Flow | $18.75M | - | - | - | $6.34M | - | - | - | ($31.95M) | - |
| CapEx | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - | - | - | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | - | - | - | - | - | - | - | - | - |
| Operating margin | - | - | - | - | - | - | - | - | - | - |
| EBITDA margin | - | - | - | - | - | - | - | - | - | - |
| Net margin | - | - | - | - | - | - | - | - | - | - |
| Free cash flow margin | - | - | - | - | - | - | - | - | - | - |
| FCF / Net income | - | - | - | - | - | - | - | - | - | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | - | - | - | - | - | - | - | - | - | - |
| Effective tax rate | - | - | 0.0% | 0.0% | 0.2% | - | 1.0% | - | - | - |
| Return on assets | -1.0% | - | 0.4% | 0.9% | 0.2% | - | 0.9% | 1.2% | 1.7% | - |
| Return on equity | -2.3% | - | 1.0% | 2.1% | 0.5% | - | 2.0% | 2.7% | 3.7% | - |
| Return on invested capital | - | - | -1.5% | -1.6% | -1.5% | - | -1.7% | - | - | - |
| Liquidity | ||||||||||
| Current ratio | - | - | - | - | - | - | - | - | - | - |
| Quick ratio | - | - | - | - | - | - | - | - | - | - |
| Cash ratio | - | - | - | - | - | - | - | - | - | - |
| Leverage | ||||||||||
| Debt / Equity | 1.35 | 1.24 | 1.23 | 1.22 | 1.24 | 1.18 | 1.14 | 1.17 | 1.11 | 1.14 |
| Debt / Assets | 0.56 | 0.54 | 0.54 | 0.54 | 0.54 | 0.53 | 0.52 | 0.53 | 0.51 | 0.52 |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | -1.6x | - | -1.7x | -1.7x | -1.7x | - | -1.7x | -1.7x | -1.7x | - |
| Equity multiplier | 2.40 | 2.30 | 2.28 | 2.28 | 2.29 | 2.24 | 2.20 | 2.22 | 2.16 | 2.19 |
| Liabilities / Assets | 0.58 | 0.56 | 0.56 | 0.56 | 0.56 | 0.55 | 0.54 | 0.55 | 0.54 | 0.54 |
| Efficiency | ||||||||||
| Asset turnover | - | - | - | - | - | - | - | - | - | - |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - | - | - | - | - | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | 28.9x | - | 31.0x | 30.7x | 38.0x | - | 28.9x | 31.8x | 27.4x | - |
| P / B | 0.7x | - | 0.7x | 0.7x | 0.9x | - | 0.9x | 0.9x | 0.9x | - |
| P / S | - | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | 12.6% | - | 12.0% | 4.1% | 6.3% | - | -5.2% | -144.2% | -23.6% | - |
| Net income growth (YoY) | - | - | -53.5% | -26.4% | -86.1% | - | -32.5% | -9.7% | 72.8% | - |
| EPS growth (YoY) | -6.7% | - | -28.1% | -22.0% | -28.6% | - | 8.5% | 5.4% | 16.7% | - |
| EPS CAGR (3y) | -8.0% | - | -4.0% | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | -7.3% | -4.7% | -4.6% | -3.7% | -3.3% | -0.3% | 2.5% | 3.7% | 4.6% | 21.2% |
Dividends
$1.76/share trailing 12 months · -9.3% YoY
| Ex-date | Per share |
|---|---|
| May 29, 2026 | $0.0300 |
| Mar 31, 2026 | $0.4200 |
| Dec 31, 2025 | $0.4200 |
| Sep 30, 2025 | $0.4200 |
| Aug 29, 2025 | $0.0500 |
| Jun 30, 2025 | $0.4200 |
| May 30, 2025 | $0.0500 |
| Mar 31, 2025 | $0.4200 |
| Feb 28, 2025 | $0.0500 |
| Dec 31, 2024 | $0.4200 |
| Nov 29, 2024 | $0.0700 |
| Sep 30, 2024 | $0.4200 |
| Aug 30, 2024 | $0.0900 |
| Jun 28, 2024 | $0.4200 |
| May 31, 2024 | $0.1100 |
| Mar 27, 2024 | $0.4100 |
| Feb 28, 2024 | $0.1000 |
| Dec 28, 2023 | $0.4100 |
| Nov 29, 2023 | $0.0900 |
| Sep 28, 2023 | $0.4100 |
| Aug 30, 2023 | $0.0800 |
| Jun 29, 2023 | $0.4100 |
| Mar 30, 2023 | $0.4100 |
| Dec 29, 2022 | $0.4100 |